Oesophageal Carcinoma Completed Phase 3 Trials for Irinotecan (DB00762)

Also known as: Carcinoma of Esophagus / Esophageal Carcinoma / Carcinoma, Esophageal / Esophagus Carcinoma / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Oesophageal carcinoma NOS / Esophageal carcinoma NOS

IndicationStatusPhase
DBCOND0032513 (Oesophageal Carcinoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03099382Study of SHR-1210 Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal CancerTreatment